January 5, 2018 / 2:26 PM / 6 months ago

BRIEF-Retrophin And Censa Pharmaceuticals Enter Into Strategic Collaboration To Advance Cnsa-001

Jan 5 (Reuters) - Retrophin Inc:

* RETROPHIN AND CENSA PHARMACEUTICALS ENTER INTO STRATEGIC COLLABORATION TO ADVANCE CNSA-001 FOR THE TREATMENT OF PHENYLKETONURIA (PKU)

* RETROPHIN INC - ‍UNDER DEAL TERMS , CO IS MAKING A $10 MILLION UPFRONT PAYMENT TO CENSA AND WILL PROVIDE FUNDING FOR DEVELOPMENT OF CNSA-001 IN PKU​

* RETROPHIN - UNDER DEAL TERMS, ‍CENSA WILL RUN DEVELOPMENT PROGRAM FOR CNSA-001​, WHICH WILL BE CONDUCTED UNDER OVERSIGHT OF A JOINT STEERING COMMITTEE Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below